Taiho Oncology
NJ - Princeton
BiotechnologyFocus: Oncology small molecules
Taiho Oncology is a life sciences company focused on Oncology small molecules.
Oncology
Employees
5000+
Open Jobs
0
Products & Portfolio (3)
Pipeline & Clinical Trials
TAS-102
Colorectal Cancer MetastaticClinical Trials (1)
NCT02286492Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
N/AThe CHOICE Registry
Metastatic Colorectal CancerClinical Trials (1)
NCT03148093The CHOICE Registry
N/ATAS-120
Advanced CholangiocarcinomaClinical Trials (1)
NCT04507503Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
N/ATAS-102 tablets
Advanced Solid Tumors (Excluding Breast Cancer)Clinical Trials (1)
NCT01874522Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI
Phase 1ASTX727
Acute Myeloid LeukemiaClinical Trials (1)
NCT04953897Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
Phase 1Phase 1
Clinical Trials (1)
NCT02566772Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer
Phase 1Phase 1
Clinical Trials (1)
NCT04980404Inqovi Maintenance Therapy in Myeloid Neoplasms
Phase 1TAS4464
Multiple MyelomaClinical Trials (1)
NCT02978235A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma
Phase 1TAS-119
Advanced Solid TumorsClinical Trials (1)
NCT02448589An Investigation of TAS-119 Monotherapy
Phase 1Phase 1
Clinical Trials (1)
NCT05403450A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Phase 1Phase 1
Clinical Trials (1)
NCT03410927A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities
Phase 1S-1/Cisplatin
Impaired Hepatic FunctionClinical Trials (1)
NCT00398424Evaluating Patients With Impaired Hepatic Function
Phase 1TAS-102
Advanced Solid TumorsClinical Trials (1)
NCT02301104A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Phase 1Phase 1
Clinical Trials (1)
NCT01916447A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Phase 1ASTX295
Solid TumorClinical Trials (1)
NCT03975387Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
Phase 1TAS-102
Advanced Solid TumorsClinical Trials (1)
NCT01867866Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone
Phase 1ASTX727
Acute Myeloid LeukemiaClinical Trials (1)
NCT04953910Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
Phase 1Phase 1
Clinical Trials (1)
NCT04586270A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer
Phase 1TAS-114/capecitabine
NeoplasmsClinical Trials (1)
NCT02025803A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors
Phase 1TAS-114
Advanced Solid TumorsClinical Trials (1)
NCT02454062A Trial of TAS-114 in Combination With S-1
Phase 1S-1/Cisplatin
Renal ImpairmentClinical Trials (1)
NCT00398307Evaluating Patients With Varying Degrees of Renal Function
Phase 1Phase 1
Clinical Trials (1)
NCT01867879Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors
Phase 1TAS-116
Advanced Solid TumorsClinical Trials (1)
NCT02965885A Study of TAS-116 in Patients With Solid Tumors
Phase 1Decitabine and Cedazuridine
Acute Myeloid LeukemiaTAS2940
Solid TumorClinical Trials (1)
NCT04982926A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
Phase 1S-1
TumorsClinical Trials (1)
NCT00400023A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
Phase 1TAS1440
Acute Myeloid LeukemiaClinical Trials (1)
NCT04282668A Study of TAS1440 With ATRA in Subjects With r/r AML
Phase 1Clinical Trials (1)
NCT04770246TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations
Phase 1TAS-119
Advanced Solid TumorsClinical Trials (1)
NCT02134067Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Phase 1Lonsurf
Pancreatic CancerClinical Trials (1)
NCT04046887Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
Phase 1Futibatinib and Binimetinib
Advanced or Metastatic Solid Tumors Irrespective of Gene AlterationsClinical Trials (1)
NCT04965818Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
Phase 1TAS-102
Advanced Solid TumorsClinical Trials (1)
NCT02301117A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Phase 1TAS-102 with a light tracer dose of [14C]FTD
Advanced Solid TumorsClinical Trials (1)
NCT02031055Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors
Phase 1ASTX660
Solid TumorsClinical Trials (1)
NCT02503423Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Phase 1/2Decitabine and Cedazuridine
Acute Myeloid LeukemiaClinical Trials (1)
NCT04657081Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT00072787Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT04742634Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
Phase 1/2Nanoliposomal Irinotecan
Colorectal AdenocarcinomaFutibatinib
CholangiocarcinomaClinical Trials (1)
NCT02052778A Study of TAS-120 in Patients With Advanced Solid Tumors
Phase 1/2TAS-102
Colorectal CancerClinical Trials (1)
NCT03223779Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Phase 1/2ASTX029
Solid Tumor, AdultClinical Trials (1)
NCT03520075Study of ASTX029 in Subjects With Advanced Solid Tumors
Phase 1/2TAS3351 oral administration
Non-Small Cell Lung CancerClinical Trials (1)
NCT05765734A Study of TAS3351 in NSCLC Patients With EGFRmt
Phase 1/2Oral Decitabine/Cedazuridine
Malignant MelanomaClinical Trials (1)
NCT05089370Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
Phase 1/2ASTX727 LD
Myelodysplastic SyndromesClinical Trials (1)
NCT03502668Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
Phase 1/2Biospecimen Collection
Lung Non-Squamous Non-Small Cell CarcinomaClinical Trials (1)
NCT07229339Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Phase 2TAS-102
Squamous Cell Lung CarcinomaClinical Trials (1)
NCT02920476TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)
Phase 2Phase 2
Clinical Trials (1)
NCT01904253A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
Phase 2TAC-101
Hepatocellular CarcinomaClinical Trials (1)
NCT00687596Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
Phase 2Phase 2
Clinical Trials (1)
NCT02855125A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1
Phase 2Futibatinib
Advanced and Metastatic Urothelial CancerOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2002
Portfolio: 3 approved products, 50 clinical trials
Top TAs: Oncology, Infectious Diseases
Portfolio Health
Peak3 (100%)
3 total products